FDA Label Change for Hormone Replacement Therapy Products
For over two decades, following a study run by the Women’s Health Initiative (WHI) regarding the role of estrogen and progestin in women, the FDA placed a black box warning on Hormone Replacement Therapy (HRT) products for menopause, noting risk of cardiovascular disease, breast cancer and dementia.


